A detailed history of Lri Investments, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Lri Investments, LLC holds 949 shares of CRL stock, worth $179,674. This represents 0.02% of its overall portfolio holdings.

Number of Shares
949
Previous 2,212 57.1%
Holding current value
$179,674
Previous $457 Million 59.13%
% of portfolio
0.02%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$187.96 - $245.29 $237,393 - $309,801
-1,263 Reduced 57.1%
949 $187 Million
Q2 2024

Jul 24, 2024

BUY
$206.39 - $268.73 $454,057 - $591,206
2,200 Added 18333.33%
2,212 $457 Million
Q1 2024

May 21, 2024

SELL
$203.52 - $273.43 $450,186 - $604,827
-2,212 Reduced 99.46%
12 $3.25 Million
Q1 2024

May 14, 2024

BUY
$203.52 - $273.43 $452,628 - $608,108
2,224 New
2,224 $508 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.63B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Lri Investments, LLC Portfolio

Follow Lri Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lri Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lri Investments, LLC with notifications on news.